Pre‐operative pulmonary artery pulsatility index does not predict mortality post‐cardiac transplantation

AIMS: The pulmonary artery pulsatility index (PAPi) is a novel haemodynamic marker that has previously been shown to predict right ventricular dysfunction and mortality in patients with pulmonary hypertension and advanced heart failure. Utility of the PAPi in predicting outcomes post‐cardiac transplantation is unknown. The aim of this study was to compare the prognostic significance of PAPi against pulmonary vascular resistance (PVR) for the predication of morbidity and all‐cause mortality post‐transplantation. METHODS AND RESULTS: All patients who underwent cardiac transplantation over a 6 year period were studied. Pre‐operative right heart catheter data was obtained. The PAPi was calculated as follows: (systolic pulmonary artery pressure [sPAP] − diastolic pulmonary artery pressure [dPAP])/right atrial (RA) pressure. One hundred fifty‐eight patients with a mean age of 49 ± 14 years were studied (43 with a pre‐transplant left ventricular assist device [LVAD]). Three patients were excluded due to missing data. In the non‐LVAD group, there was no significant difference in PAPi or PVR, nor was there any association with post‐operative outcome (including stratification by natural history sub‐type; all P > 0.05). In the LVAD group, there was no association with PAPi and post‐operative outcome; however, PVR was predictive of post‐operative mortality (mortality: 2.8 ± 1.3 WU vs. alive: 1.7 ± 0.7 WU; P = 0.005). CONCLUSIONS: The PAPi was not able to discriminate mortality outcomes for patients post‐cardiac transplantation. Pulmonary vascular resistance remains a marker of mortality in an LVAD cohort bridged to transplant (central illustration).